Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

TrueBlue, Inc. Common Stock (NY:TBI)

4.960 -0.060 (-1.20%)
Streaming Delayed Price Updated: 10:03 AM EDT, Apr 7, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about TrueBlue, Inc. Common Stock

< Previous 1 2 3 4 5 6 Next >
Discover the top movers in Tuesday's pre-market session.
Discover the top movers in Tuesday's pre-market session and stay informed about market dynamics. 
Via Chartmill
TrueBlue Reports Fourth Quarter and Full-Year 2024 Results
From TrueBlue
Via Business Wire
Earnings Scheduled For February 19, 2025
Via Benzinga
12 Industrials Stocks Moving In Friday's Pre-Market Session
Via Benzinga
TMP Worldwide UK to Provide Recruitment Services for Serco in Landmark UK Armed Forces Contract
From TrueBlue
Via Business Wire
TrueBlue: Q4 Earnings Insights
Via Benzinga
Earnings Scheduled For February 21, 2024
Companies Reporting Before The Bell • Gatos Silver (NYSE:GATO) is estimated to report quarterly earnings at $0.09 per share on revenue of $83.00 million. 
Via Benzinga
12 Industrials Stocks Moving In Thursday's Pre-Market Session
Via Benzinga
TrueBlue to Announce Fourth Quarter and Full-Year 2024 Results
From TrueBlue
Via Business Wire
TrueBlue Accelerates Diversification into Attractive Healthcare Industry with Accretive Acquisition of Healthcare Staffing Professionals, Inc.
From TrueBlue Inc.
Via Business Wire
TrueBlue Reports Third Quarter 2024 Results
From TrueBlue
Via Business Wire
TrueBlue to Announce Third Quarter 2024 Results
From TrueBlue
Via Business Wire
TrueBlue to Participate in the Sidoti Virtual Investor Conference
From TrueBlue
Via Business Wire
TBI Stock Earnings: TrueBlue Misses EPS, Misses Revenue for Q2 2024
TBI stock results show that TrueBlue missed analyst estimates for earnings per share and missed on revenue for the second quarter of 2024. 
Via InvestorPlace
TrueBlue Reports Second Quarter 2024 Results
From TrueBlue
Via Business Wire
TrueBlue to Announce Second Quarter 2024 Results
From TrueBlue
Via Business Wire
TrueBlue to Participate in the Sidoti Virtual Investor Conference
From TrueBlue
Via Business Wire
TrueBlue to Participate in the Baird Global Consumer, Technology & Services Conference
From TrueBlue
Via Business Wire
TBI Stock Earnings: TrueBlue Beats EPS, Beats Revenue for Q1 2024
TBI stock results show that TrueBlue beat analyst estimates for earnings per share and beat on revenue for the first quarter of 2024. 
Via InvestorPlace
TrueBlue Reports First Quarter 2024 Results
From TrueBlue
Via Business Wire
TrueBlue to Announce First Quarter 2024 Results
From TrueBlue
Via Business Wire
TrueBlue Completes Previously Announced Sale of PeopleReady’s Canadian Staffing Business
From TrueBlue
Via Business Wire
12 Industrials Stocks Moving In Wednesday's After-Market Session
Via Benzinga
TrueBlue Reports Fourth Quarter and Full-Year 2023 Results
From TrueBlue
Via Business Wire
TrueBlue Announces Sale of PeopleReady’s Canadian Staffing Business
From TrueBlue
Via Business Wire
TrueBlue to Announce Fourth Quarter and Full-Year 2023 Results
From TrueBlue
Via Business Wire
TrueBlue to Participate in the Sidoti Virtual Investor Conference
From TrueBlue
Via Business Wire
$1.5M Bet On This Financial Services Stock? Check Out These 4 Stocks Insiders Are Buying
Although U.S. stocks closed higher on Wednesday following Fed’s interest-rate decision, there were a few notable insider trades. 
Via Benzinga
Nasdaq Gains 100 Points; Coca-Cola Earnings Top Expectations
U.S. stocks traded higher toward the end of trading, with the Dow Jones index gaining over 200 points on Tuesday. The Dow traded up 0.67% to 33,155.68 while the NASDAQ rose 0.78% to 13,120.31. The S&P... 
Via Benzinga
Topics Stocks
Exposures US Equities
Why Asbury Automotive Group Shares Are Trading Lower By Over 6%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Gainers InMed Pharmaceuticals Inc. (NASDAQ: INM) shares climbed 169% to $1.56 after the company announced it selected a lead Alzheimer's drug candidate following proof-of-concept study data. 
Via Benzinga
< Previous 1 2 3 4 5 6 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.